Nanodelivery approaches of phytoactives for skin cancers: Current and future perspectives
dc.authorid | 0000-0001-5724-9809 | en_US |
dc.authorwosid | AAD-8509-2020 | en_US |
dc.contributor.author | Alğın Yapar, Evren | |
dc.contributor.author | Nur Özdemir, Merve | |
dc.contributor.author | Durgun, Meltem Ezgi | |
dc.contributor.author | Akbal Dağıstan, Özlem | |
dc.contributor.author | Cavalu, Simona | |
dc.contributor.author | Özsoy, Yıldız | |
dc.contributor.author | Kartal, Murat | |
dc.date.accessioned | 2024-05-02T10:18:38Z | |
dc.date.available | 2024-05-02T10:18:38Z | |
dc.date.issued | 2024 | en_US |
dc.department | Fakülteler, Eczacılık Fakültesi, Eczacılık Teknoloji Bölümü, Farmasötik Teknoloji Ana Bilim Dalı | en_US |
dc.description.abstract | In recent years, there has been an increase in skin cancers due to external factors, especially environmental factors, and studies on treatment alternatives have gained importance. Nanomaterials are common, from sunscreen formulas to formulations designed to treat skin cancers at various stages. Using bioactives has multiple effects in treating skin cancers, which provides many advantages. In this regard, many phytochemicals gain importance with their antioxidant, anti-proliferative, anti-inflammatory, antiangiogenic, and analgesic effects. Their delivery with nanocarriers is on the agenda for phytochemicals to gain the targeted stability, effectiveness, and toxicity/safety properties. This review presents types of skin cancers, phytochemicals effective in skin cancers, and their nanocarrier-loaded studies from an up-to-date perspective. | en_US |
dc.identifier.citation | Alğın Yapar, E., Nur Özdemir, M., Durgun, M. E., Akbal Dağıstan, Ö., Cavalu, S., Özsoy, Y., & Kartal, M. (2024). Nanodelivery approaches of phytoactives for skin cancers: Current and future perspectives. Current Pharmaceutical Biotechnology. https://doi.org/10.2174/0113892010300081240329033208 | en_US |
dc.identifier.doi | 10.2174/0113892010300081240329033208 | en_US |
dc.identifier.issn | 1389-2010 | |
dc.identifier.issn | 1873-4316 | |
dc.identifier.pmid | PMID: 38616742 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.uri | https://doi.org/10.2174/0113892010300081240329033208 | |
dc.identifier.uri | https://hdl.handle.net/20.500.13055/695 | |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.indekslendigikaynak.other | SCI-E - Science Citation Index Expanded | en_US |
dc.institutionauthor | Durgun, Meltem Ezgi | |
dc.language.iso | en | en_US |
dc.publisher | Bentham Science Publishers | en_US |
dc.relation.ispartof | Current Pharmaceutical Biotechnology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Phytochemicals | en_US |
dc.subject | Nanocarriers | en_US |
dc.subject | Skin Cancer Types | en_US |
dc.subject | Melanoma | en_US |
dc.subject | Non-Melanoma | en_US |
dc.subject | Patents on Bioactive | en_US |
dc.title | Nanodelivery approaches of phytoactives for skin cancers: Current and future perspectives | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication |
Dosyalar
Lisans paketi
1 - 1 / 1
Kapalı Erişim
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: